Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Harrow Health ( (HROW) ) just unveiled an update.
On September 26, 2025, Harrow, Inc. entered into a New Credit Agreement with Fifth Third Bank for a senior secured revolving credit facility of $40 million, with an additional uncommitted $20 million line of credit. The agreement, maturing in 2030, includes covenants and financial requirements, impacting Harrow’s financial operations and strategic flexibility.
The most recent analyst rating on (HROW) stock is a Buy with a $63.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
Harrow Health’s overall stock score is driven by strong earnings call results and positive technical indicators, indicating growth potential. However, significant financial performance challenges and valuation concerns weigh heavily on the score. Addressing cash flow issues and improving profitability are crucial for enhancing financial stability.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Average Trading Volume: 582,498
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.74B
For an in-depth examination of HROW stock, go to TipRanks’ Overview page.